Lund University Hospital
🇸🇪Sweden
- Country
- 🇸🇪Sweden
- Ownership
- Private
- Established
- 1768-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.skane.se/sus
Clinical Trials
64
Active:2
Completed:37
Trial Phases
6 Phases
Early Phase 1:2
Phase 1:5
Phase 2:11
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (49 trials with phase data)• Click on a phase to view related trials
Not Applicable
20 (40.8%)Phase 2
11 (22.4%)Phase 3
9 (18.4%)Phase 1
5 (10.2%)Early Phase 1
2 (4.1%)Phase 4
2 (4.1%)The Impact of Dental Health on Complications During and Following Radiotherapy in the Head and Neck Region.
Completed
- Conditions
- Head and Neck NeoplasmsRadiotherapy; ComplicationsExtracting Own Teeth
- First Posted Date
- 2025-02-21
- Last Posted Date
- 2025-02-21
- Lead Sponsor
- Lund University Hospital
- Target Recruit Count
- 750
- Registration Number
- NCT06840639
- Locations
- 🇸🇪
Oral and Maxillofacial department, Lund, Skåne, Sweden
Arthroscopy of the Temporomandibular Joint. On Jaw Mobility, Pain and HRQoL
Completed
- Conditions
- Arthroscopic SurgeryObservationalTemporomandibular JointHealth-Related Quality Of LifeFollow-Up Studies
- First Posted Date
- 2024-05-29
- Last Posted Date
- 2024-05-29
- Lead Sponsor
- Lund University Hospital
- Target Recruit Count
- 127
- Registration Number
- NCT06433154
- Locations
- 🇸🇪
Dept Oral and Maxillofacial Surgery, Lund, Sweden
🇸🇪Martin Bengtsson, Lund, Sweden
A Phase 2, Open Label Study of PEmigatinib and REtifanlimab in Advanced Dedifferentiated LIposarcoma (PERELI)
Phase 2
Recruiting
- Conditions
- Dedifferentiated Liposarcoma
- Interventions
- First Posted Date
- 2024-04-29
- Last Posted Date
- 2024-10-08
- Lead Sponsor
- Lund University Hospital
- Target Recruit Count
- 33
- Registration Number
- NCT06389799
- Locations
- 🇳🇴
Oslo University Hospital HF, Oslo, Norway
🇸🇪Sahlgrenska University Hospital, Göteborg, Sweden
🇸🇪Skåne University Hospital, Lund, Sweden
a Multicentre Phase III Study of Risk-based Treatment Intensification With Hyperfractionated Radiotherapy in Head and Neck Cancer Patients
Phase 3
Recruiting
- Conditions
- Head and Neck Squamous Cell Carcinoma
- First Posted Date
- 2024-02-08
- Last Posted Date
- 2024-02-08
- Lead Sponsor
- Lund University Hospital
- Target Recruit Count
- 308
- Registration Number
- NCT06248996
- Locations
- 🇸🇪
Gävle Hospital, Gävle, Sweden
🇸🇪Sahlgrenska University Hospital, Göteborg, Sweden
🇸🇪Jönköping Hospital, Jönköping, Sweden
Standardized Osteotomy Guides for Free Flap Reconstruction of Continuous Defects of the Jaws - a Simplified Method
- Conditions
- Oral Surgical ProceduresSurgery, OralMandibular Reconstruction
- First Posted Date
- 2023-02-08
- Last Posted Date
- 2024-04-11
- Lead Sponsor
- Lund University Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT05715359
- Locations
- 🇸🇪
Dept Oral and Maxillofacial Surgery, Lund, Sweden
- Prev
- 1
- 2
- 3
- 4
- 5
- 13
- Next
News
No news found